Get the Stockscreener App
1.45
9.02%
0.12
After Hours:
1.45
Rafael Holdings Inc stock is traded at $1.45, with a volume of 119.47K.
It is up +9.02% in the last 24 hours and down -14.71% over the past month.
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
See More
Previous Close:
$1.33
Open:
$1.32
24h Volume:
119.47K
Relative Volume:
1.63
Market Cap:
$56.54M
Revenue:
$697.00K
Net Income/Loss:
$-39.78M
P/E Ratio:
-0.8683
EPS:
-1.67
Net Cash Flow:
$-8.90M
1W Performance:
-5.84%
1M Performance:
-14.71%
6M Performance:
-25.64%
1Y Performance:
-8.81%
1-Day Range:
$1.32
$1.45
1-Week Range:
$1.32
$1.53
52-Week Range:
$1.29
$2.50
Rafael Holdings Inc Stock (RFL) Company Profile
Name
Rafael Holdings Inc
Sector
Industry
Phone
212-658-1450
Address
520 BROAD STREET, NEWARK
Compare RFL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RFL
Rafael Holdings Inc
|
1.45 | 56.54M | 697.00K | -39.78M | -8.90M | -1.67 |
|
CBRE
Cbre Group Inc
|
126.59 | 37.73B | 36.74B | 1.01B | 1.35B | 3.27 |
|
CSGP
Costar Group Inc
|
74.57 | 32.89B | 2.81B | 117.20M | -30.60M | 0.29 |
|
BEKE
Ke Holdings Inc Adr
|
19.30 | 24.95B | 12.30B | 566.18M | 1.32B | 0.4805 |
|
JLL
Jones Lang Lasalle Inc
|
229.63 | 11.14B | 22.50B | 478.00M | 411.90M | 9.89 |
|
FSV
Firstservice Corp
|
173.40 | 8.01B | 4.93B | 108.16M | 203.45M | 2.40 |
Rafael Holdings Inc Stock (RFL) Latest News
Rafael Holdings Enters Standby Purchase Agreement with Chairman - TipRanks
SEC Form 424B3 filed by Rafael Holdings Inc. - Quantisnow
Ekso Bionics: Q1 Earnings Snapshot - CTPost
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results - ADVFN
Rafael announces revised subscription rights in connection with offering - TipRanks
Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma - The Manila Times
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously ... - Bluefield Daily Telegraph
Rafael Holdings Launches $25M Rights Offering: Key Dates and Terms Investors Must Know - Stock Titan
United-Guardian, Inc. (NASDAQ:UG) Shares Acquired by Geode Capital Management LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Metric Deep Dive: Understanding Rafael Holdings Inc (RFL) Through its Ratios - DWinneX
Tronox Holdings plc: Navigating Market Fluctuations with a 857.28M Market Cap - investchronicle.com
Rafael Holdings Inc (RFL) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times
Sonoco Reports First Quarter 2025 Results - The Manila Times
Rafael Holdings Secures Future: $25M Rights Offering Powers Critical Phase 3 Drug Launch Plans - Stock Titan
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - The Manila Times
Rafael Holdings Strengthens its Focus on the Development of Trappsol Cyclo and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - marketscreener.com
Rafael Holdings CEO Resignation Announced - TipRanks
WillScot Announces Investor Conference Schedule for May 2025 - The Manila Times
Rafael Holdings Announces Leadership Transition Following Merger with Cyclo Therapeutics and Full Enrollment of TransportNPC™ Phase 3 Trial for Niemann-Pick Disease Treatment - Nasdaq
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces ... - Bluefield Daily Telegraph
Rafael Holdings Pivots to Breakthrough Rare Disease Drug Development as Leadership Changes - Stock Titan
SEC Form S-3 filed by Ekso Bionics Holdings Inc. - Quantisnow
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, VGR, TTNP on Behalf of Shareholders - ACCESS Newswire
General Atomics Partners With Rafael to Build Precision-Guided Missile for U.S. Defense Customers - Yahoo Finance
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GVP, AFBI, RFL, MNTX on Behalf of Shareholders - ACCESS Newswire
Autodesk announces Betsy Rafael to step down from Board of Directors - Yahoo Finance
Rafael Holdings finalizes merger with Cyclo Therapeutics By Investing.com - Investing.com South Africa
Rafael Closes Merger With Cyclo Therapeutics - MarketScreener
Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals - MarketScreener
Cyclo Therapeutics Merges with Rafael Holdings - TipRanks
Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet? - simplywall.st
Rafael Holdings Completes Merger with Cyclo Therapeutics - TipRanks
Volatility Alert: 10 Stocks Showing High IV Percentile - The Globe and Mail
Rafael Holdings finalizes merger with Cyclo Therapeutics - Investing.com
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals - GlobeNewswire
Major Pharma Merger: Rafael Holdings Gains Phase 3 Rare Disease Asset in Strategic Deal - Stock Titan
I Would Not Short Tesla Stock at Current Valuations - The Globe and Mail
Rafael Holdings secures shareholder nod for Cyclo Therapeutics merger By Investing.com - Investing.com Australia
Can SoundHound AI Double? What the Fundamentals and Deals Reveal - The Globe and Mail
Rafael Holdings secures shareholder nod for Cyclo Therapeutics merger - Investing.com
Cyclo Therapeutics shareholders approve merger with Rafael Holdings - Investing.com
TPT Global Tech Set to Broadcast First MASL Professional Indoor Soccer Game on Its VuMe Live Super App - The Globe and Mail
March Madness: Flutter Stock Is a Solid Bet on Sustained Growth - The Globe and Mail
Bull markets have begun…outside the U.S. - The Globe and Mail
Q4 Earnings Highlights: Apogee (NASDAQ:APOG) Vs The Rest Of The Commercial Building Products Stocks - The Globe and Mail
Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL) - Business Wire
Rafael Holdings Reports Q2 Fiscal 2025 Results - TipRanks
Rafael Holdings Inc Reports Q2 2025 Earnings: EPS at -$0.19, Str - GuruFocus.com
Rafael Holdings, Inc. SEC 10-Q Report - TradingView
Rafael Holdings Inc Stock (RFL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.84%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):